Condition: Intrahepatic Cholangiocarcinoma · Sponsor: Inova Health Care Services
The purpose of this research is to see if combining gemcitabine, cisplatin and Durvalumab chemotherapy treatments with a direct tumor therapy called Yittrium-90, will work better together to shrink the tumor and control cancer.
This description comes directly from the study's public registry record.
Keary Janet, BS · 571-472-0024 · keary.janet@inova.org
Elahe Mollapour · elahe.mollapour@inova.org
Always discuss trial participation with your own doctor first.
| Keary Janet | Fairfax, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05422690